Abstract

Objective: To evaluate the long-term safety and efficacy of corneal cross-linking in keratoconus patients with thin corneas. Methods: Forty eyes of 25 subjects having progressive keratoconus with thinnest corneal thickness (TCT) less than 400 µm were evaluated. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), corneal topography, and endothelial cell loss were assessed at baseline and followed at six-month interval till the end of 1st year of follow up and then yearly till the fifth year, de-epithelization of cornea was performed, followed by ultrasound pachymetry to measure TCT. Hypoosmolar riboflavin (0.1%) solution was applied after every 2 minutes for 25 minutes. Ultraviolet A (UVA) irradiation was performed for 30 minutes along with riboflavin for every 2 minutes. Results: Mean TCT was 381.5 ± 13.2 µm (range: 344–396 µm) without corneal epithelium. Following hypotonic riboflavin instillation, mean TCT increased by 97.8 ± 12.1 µm (range: 83–112 µm) for a mean thickness of 478.1 ± 14.9 µm (range: 409–506 µm). The average follow-up period was 61.79 ± 6.19 months (range: 42–68 months). Corrected distance visual acuity, pachymetry values and posterior elevation showed no significant difference before and after CXL at 5 years follow-up. Corneal astigmatism and maximum keratometry reading (Kmax) were significantly reduced. Mean reduction of endothelial cell count was 1.5% at the last follow-up visit. Conclusions: CXL with UVA and hypoosmolar riboflavin was effective in stabilizing keratoconus progression in patients with thin corneas however further studies are required to confirm our results.

Keywords: corneal cross-linking · keratoconus · riboflavin · thin cornea

References

  1. 1.Rabinowitz YS. Keratoconus. Surv Opthalomol. 1998;42:297-319.
  2. 2.Gu S, Fan Z, Wang L, et al. Corneal collagen cross-linking with hypoosmolar riboflavin solution in keratoconic corneas. Biomed Res Int. 2014. Doi: http://dx.doi.org/10.1155/2014/754182 doi:10.1155/2014/754182
  3. 3.Hashemi H, Seyedian MA, Miraftab M, et al. Collagen cross-linking with riboflavin and UltravioletAirradiation for keratoconus. Opthalmology. 2013;120:1515-1520.
  4. 4.Wollensak G, Spoerl E, Seiler T. Stress– strain measurements of human and porcine corneas after riboflavirin-ultraviolet-A-induced cross-linking. J. Cataract Refract. Surg. 2003:29:1780–1785
  5. 5.Chen X, Stojanovic A, Eidet JR, et al. Corneal collagen cross-linking (CXL) in thin corneas. Eye and Vision. 2015;2:15-
  6. 6.Doi: 10.1186 s40662-015-0025-3
  7. 7.Chunyu T, Xiujun P, Zhengjun F, Xia Z, et al. Corneal collagen cross-linking in keratoconus:Asystematicreviewandmetaanalysis. Scientific Reports. 2014;4:5662- 5669. Doi:10.1038/srep05652. doi:10.1038/srep05652
  8. 8.Raiskup F, Hoyer A, Spoerl E. Permanent corneal haze after riboflavin-UVA- induced cross-linking in keratoconus. J Refract Surg. 2009;25:S824-S828.
  9. 9.Hafezi F, Mrochen M, Iseli HP, et al. Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas. J Cataract Refract Surg. 2009; 35:621–624.
  10. 10.Tomkins O, Garzozi HJ. Collagen crosslinking: Strengthening the unstable cornea. Clin. Opthalmol. 2008;2:863-867 33 33 Majmaah Journal of Health Sciences ,Vol. 6, Issue 1, March 2018, Rajab - 1439 Long-term safety and efficacy of corneal cross-linking in thin corneas with keratoconus
  11. 11.Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA–riboflavin cross-linking of the cornea. Cornea. 2007;26:385-389.
  12. 12.S. Baiocchi, C. Mazzotta, D. Cerretani, T. Caporossi, and A. Caporossi, “Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium,” Journal of Cataract and Refractive Surgery. 2009:35:893–899,12
  13. 13.Coskunseven E, Jankov II MR, Hafezi F. Contralateral eye study of corneal collagen cross-linking with riboflavin and UVA irradiation in patients with keratoconus. J Refract Surg. 2009; 25:371-376.
  14. 14.Greenstein SA, Fry KL, Hersh PS. Corneal topography indices after corneal collagen crosslinking for keratoconus and corneal ectasia: One-year results. J Cataract Refract Surg. 2011; 37:1282–1290.
  15. 15.Goldich Y, Marcovich AL, Barkana Y. Clinicalandcornealbiomechanicalchanges after collagen crosslinking with riboflavinandUVirradiationinpatientswithprogressive keratoconus: results after 2 years of follow-up. Cornea. 2012;31:609-614.
  16. 16.Vinciguerra P, Albe E, Trazza S, et al. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. Ophthalmology. 2009;116:369-378.
  17. 17.Arora R, Jain P, Goyal JL, et al. Comparative analysis of refractive and topographic changes in early and advanced keratoconiceyesundergoingcornealcollagencrosslinking. Cornea. 2013;32(10):1359-1364.
  18. 18.Razmjoo H, Rahimi B, Kharraji M, et al. Corneal haze and visual outcome after collagen crosslinking for keratoconus: A comparison between total epithelium off and partial epithelial removal methods. Adv Biomed Res. 2014;3:221.
Majmaah Journal of Health Sciences · eISSN 1658-8223 · Majmaah University · open access